Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen's hemophilia business spin-off will trade on its own starting Thursday
Biogen's hemophilia business spin-off will trade on its own starting Thursday
Biogen's hemophilia business spin-off will trade on its own starting Thursday
Submitted by
admin
on February 1, 2017 - 10:34am
Source:
Marketwatch
News Tags:
Biogen
spinoffs
Bioverativ
hemophilia
Headline:
Biogen's hemophilia business spin-off will trade on its own starting Thursday
Do Not Allow Advertisers to Use My Personal information
